Furoxans and tocopherol analogs–furoxan hybrids as anticancer agents
- 1 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 30 (4) , 330-338
Abstract
We determined the antiproliferative and nitric oxide (NO)-releasing activity of furoxans and tocopherol analogs–furoxan hybrids by tandem Griess/resazurin/sulforhodamin B assays in HeLa, 253J, T24, and HepG2 cancer cells. In addition, to investigate the NO implications in the inhibition of cell growth, cells were pretreated with the NO scavenger hemoglobin and the genotoxic damage was determined. The compounds 1 and 3 emerged as good anticancer agents for bladder cancer treatment. The NO-releasing activity of these compounds appears to be necessary to obtain the antiproliferative effect. Although compound 1 exerted a DNA damage mechanism of action, compound 3 seemed to act in a different way. The low toxicity levels against normal cell line HaCaT point them out as a very promising scaffold for the further design of new anticancer agents.Keywords
This publication has 15 references indexed in Scilit:
- A green multicomponent synthesis of tocopherol analogues with antiproliferative activitiesEuropean Journal of Medicinal Chemistry, 2018
- Nitric Oxide Donor-Based Cancer Therapy: Advances and ProspectsJournal of Medicinal Chemistry, 2017
- QSAR studies and design of new analogs of vitamin E with enhanced antiproliferative activity on MCF-7 breast cancer cellsJournal of the Taiwan Institute of Chemical Engineers, 2016
- Synthesis and biological evaluation of novel histone deacetylases inhibitors with nitric oxide releasing activityBioorganic & Medicinal Chemistry, 2015
- Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide DonorJournal of Medicinal Chemistry, 2015
- Genetic toxicology and preliminaryin vivostudies of nitric oxide donor tocopherol analogs as potential new class of antiatherogenic agentsDrug and Chemical Toxicology, 2011
- Second generation of α-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterizationBioorganic & Medicinal Chemistry, 2007
- Design, synthesis, and biological characterization of potential antiatherogenic nitric oxide releasing tocopherol analogsBioorganic & Medicinal Chemistry, 2005
- Pharmacological Properties of Furoxans and Benzofuroxans: Recent DevelopmentsMini-Reviews in Medicinal Chemistry, 2005
- 176. The 3,4-bisarenesulphonylfuroxansJournal of the Chemical Society (Resumed), 1964